AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +27.3% | 43,873 | +43.8% | 0.00% | – |
| Q2 2022 | $11,000 | -86.2% | 30,502 | +28.4% | 0.00% | – |
| Q1 2021 | $80,000 | -80.0% | 23,759 | -83.4% | 0.00% | -100.0% |
| Q4 2020 | $400,000 | +8.1% | 142,806 | -3.2% | 0.00% | +100.0% |
| Q3 2020 | $370,000 | -83.8% | 147,538 | -12.1% | 0.00% | -90.9% |
| Q2 2020 | $2,278,000 | +37.1% | 167,813 | -23.4% | 0.01% | 0.0% |
| Q1 2020 | $1,661,000 | -22.7% | 219,106 | -35.6% | 0.01% | +57.1% |
| Q4 2019 | $2,150,000 | +50.1% | 340,175 | -6.9% | 0.01% | +40.0% |
| Q3 2019 | $1,432,000 | -68.3% | 365,347 | -60.9% | 0.01% | -68.8% |
| Q2 2019 | $4,524,000 | -6.1% | 934,650 | +58.8% | 0.02% | -11.1% |
| Q1 2019 | $4,819,000 | +119.0% | 588,408 | +47.9% | 0.02% | +80.0% |
| Q4 2018 | $2,200,000 | -18.6% | 397,804 | +30.0% | 0.01% | 0.0% |
| Q3 2018 | $2,703,000 | +20.8% | 306,119 | +36.5% | 0.01% | +11.1% |
| Q2 2018 | $2,238,000 | +16.6% | 224,219 | +11.3% | 0.01% | 0.0% |
| Q1 2018 | $1,920,000 | – | 201,419 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |